The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up.
about
Vaginal dischargeInfluence of the tryptophan-indole-IFNγ axis on human genital Chlamydia trachomatis infection: role of vaginal co-infectionsMorphologic and molecular evaluation of Chlamydia trachomatis growth in human endocervix reveals distinct growth patterns.Serovar D and E of serogroup B induce highest serological responses in urogenital Chlamydia trachomatis infections.Estimating Local Chlamydia Incidence and Prevalence Using Surveillance DataA randomised trial of point-of-care tests for chlamydia and gonorrhoea infections in remote Aboriginal communities: Test, Treat ANd GO- the "TTANGO" trial protocol.The natural history of trachoma infection and disease in a Gambian cohort with frequent follow-upChlamydia (uncomplicated, genital).Immunobiological outcomes of repeated chlamydial infection from two models of within-host population dynamics.Distribution study of Chlamydia trachomatis genotypes in symptomatic patients in Buenos Aires, Argentina: association between genotype E and neonatal conjunctivitis.Current crisis or artifact of surveillance: insights into rebound chlamydia rates from dynamic modelling.Usefulness of primary care electronic networks to assess the incidence of chlamydia, diagnosed by general practitioners.A Stochastic Model for Assessing Chlamydia trachomatis Transmission Risk Using Longitudinal Observational DataProtective immunity to Chlamydia trachomatis genital infection: evidence from human studies.Pelvic inflammatory disease: current concepts in pathogenesis, diagnosis and treatmentInterruption of CXCL13-CXCR5 axis increases upper genital tract pathology and activation of NKT cells following chlamydial genital infection.Heterogeneity in risk of pelvic inflammatory diseases after chlamydia infection: a population-based study in Manitoba, Canada.Immunoglobulin-Based Investigation of Spontaneous Resolution of Chlamydia trachomatis Infection.Chlamydia trachomatis Infection: Screening and Management.Management of Chlamydia trachomatis genital tract infection: screening and treatment challenges.Intrauterine devices & infection: review of the literature.Enrofloxacin and macrolides alone or in combination with rifampicin as antimicrobial treatment in a bovine model of acute Chlamydia psittaci infection.Contribution of IL-12A and IL-12B polymorphisms to Chlamydia trachomatis-specific cell-mediated immune responses.Chlamydia trachomatis infection control programs: lessons learned and implications for vaccine developmentInhibition of indoleamine 2,3-dioxygenase activity by levo-1-methyl tryptophan blocks gamma interferon-induced Chlamydia trachomatis persistence in human epithelial cellsNatural Course of Chlamydia trachomatis Bacterial Load in the Time Interval between Screening and Treatment in Anogenital Samples.Chlamydia trachomatis Infection of Endocervical Epithelial Cells Enhances Early HIV Transmission Events.Human and Pathogen Factors Associated with Chlamydia trachomatis-Related Infertility in WomenAssociation between sexually transmitted diseases and young adults' self-reported abstinence.Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala Women's Cohort Study.Chlamydia trachomatis infection results in a modest pro-inflammatory cytokine response and a decrease in T cell chemokine secretion in human polarized endocervical epithelial cellsThe cost effectiveness of opportunistic chlamydia screening in England.Community-based trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial.Immunity, immunopathology, and human vaccine development against sexually transmitted Chlamydia trachomatisPgp3 antibody enzyme-linked immunosorbent assay, a sensitive and specific assay for seroepidemiological analysis of Chlamydia trachomatis infection.Modulation of MICA on the surface of Chlamydia trachomatis-infected endocervical epithelial cells promotes NK cell-mediated killing.Cell Intrinsic Factors Modulate the Effects of IFNγ on the Development of Chlamydia trachomatis.Chlamydia trachomatis OmpA genotyping as a tool for studying the natural history of genital chlamydial infection.Chlamydia in gynecologic practice.Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening.
P2860
Q24684710-8110E6B1-D785-477A-9238-8EC16FCCA643Q26991442-4794AEC5-CD06-4AAB-9500-6E5E26150AABQ30580287-D9F09E12-C52C-4E4D-A979-29BFC5A38101Q30616758-880804F8-FF8E-4C84-9754-277962ADE092Q30854606-9C7BDC78-62F6-457F-84CC-9514BC92D57EQ31141987-64B85CA3-1179-4E42-9D16-849426877827Q33388677-1CD11CE3-D276-412A-A68D-AE203FEFA6D8Q33446523-AA570A25-7745-4A9F-A94D-A8BC1E21CD31Q33499684-F97C99B0-A635-4F41-BDF8-655B4F5DF11FQ33533970-A93DAFDF-DEDE-4A15-B9C1-C05BD1C24D54Q33541279-18B2797A-8389-48D3-8E0A-1B915E8D0D6DQ33955823-8DCC5CE5-8566-4DF8-BCCC-B47CFF97473FQ34055102-D952357C-3776-40AD-9E02-D0C3C3F85AE6Q34345929-D17DB6CC-5ED5-4EAB-A522-0EF46FC52AEFQ34387781-FDD9B35B-2851-4075-B161-1BD87B37BC3FQ34493665-EC5624B3-C254-4AB4-94D9-CA0DFC733B79Q34509538-9566507F-A538-4466-8868-5148ADB5F9D1Q34555849-B35F45EA-E042-4342-A0D9-164EE0255E2EQ34785987-4E8517A5-3730-4C68-AAFB-28C5A55977D4Q35026625-4A26BA5C-C881-436A-8313-18880C0BC40EQ35135264-6D3497C5-623A-48FF-93A4-6FBAB52B6264Q35175244-4BFCB761-3AAE-42C2-ACEE-50C06A2D298EQ35539185-AF9FE16B-1823-494E-B3D6-12D3B9E687F8Q35582346-B15B6569-D15E-4932-B757-8712864E8ECEQ35671624-94ABDF06-4FD6-4B30-AFA0-9219F139C09CQ35880483-ABBEF364-6767-43D3-BC0C-2FE26AFE09C7Q35885053-7D9A8898-DF12-4839-9BE1-5CD0D6A6DE27Q35992863-E5416C6F-6BB4-4C7B-BEB0-D60B924EAA63Q36071085-4E2E4107-73AC-4FD1-BDE4-A811E13F2580Q36958201-47666390-790A-47E4-8119-3B88696BDF6EQ36990651-BB1D9E55-3510-490E-9434-77D5CD73F4F2Q37006317-42F3AE53-9346-464C-BFD7-E7CEA9871517Q37040094-D1313756-5415-4C6B-890E-63B392DBB138Q37159712-4A1276A5-9F3D-43E5-A1D8-30B9A43DDDCFQ37213912-A125E58E-42B5-4088-9FC8-B970F56DD310Q37268070-CE1BADA9-0C1A-42AB-BB88-CB05564C6E6BQ37292585-EEF806EF-75DC-4D31-96D0-AFAC8F544DD2Q37361304-E573A8AC-5941-4892-845D-AD6296BAB082Q37608361-FA9AC4BA-B10B-4060-A786-A631D31685EBQ37614736-DECE634C-31AA-465B-BE7E-ECBB0E9C61FB
P2860
The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2002
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The natural course of asymptom ...... PID after one-year follow-up.
@en
The natural course of asymptom ...... PID after one-year follow-up.
@nl
type
label
The natural course of asymptom ...... PID after one-year follow-up.
@en
The natural course of asymptom ...... PID after one-year follow-up.
@nl
prefLabel
The natural course of asymptom ...... PID after one-year follow-up.
@en
The natural course of asymptom ...... PID after one-year follow-up.
@nl
P2093
P1476
The natural course of asymptom ...... l PID after one-year follow-up
@en
P2093
A Joan P Boeke
Adriaan J C van den Brule
Chris J L M Meijer
Feja J Voorhorst
Lawrence Rozendaal
Sjoerd de Blok
P356
10.1258/095646202762226092
P478
13 Suppl 2
P50
P577
2002-12-01T00:00:00Z